Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice.

Science Translational Medicine(2022)10.1126/scitranslmed.abj5305Source: DataRank Database

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice. is a research paper published in Science Translational Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 69 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access69 citations

Download PDF

Cite:

Linked data & code

gen gisaid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 6.57)OA: hybridTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (46)

Francesco Borriello ORCID,Timothy R. O’Meara ORCID,Marisa E. McGrath ORCID,Yoshine Saito ORCID,Robert Haupt ORCID

Live enrichment

PubMed:34783582 PMC:PMC10176044 OpenAlex:https://openalex.org/W3212576317

NIAID NIH HHS

Grant: HHSN272201400007C

NIAID NIH HHS

Grant: R21 AI137932

NIAID NIH HHS

Grant: R01 AI121066

NIAID NIH HHS

Grant: R01 AI146779

NIAID NIH HHS

Grant: R01 AI148166

NIAID NIH HHS

Grant: 75N93019C00044

NIAID NIH HHS

Grant: HHSN272201800047C

NIGMS NIH HHS

Grant: T32 GM007753

NIDDK NIH HHS

Grant: R01 DK115217

NIAID NIH HHS

Grant: T32 AI007245

NIAID NIH HHS

Grant: HHSN272201400052C

NIAID NIH HHS

Grant: R01 AI165505

FWCI

6.57

Citation Percentile

1.0%

Citation Trend

2015

2022

2023

2024

2025

hybridLicense: cc-by

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10176044/pdf/nihms-1884651.pdf

publisherhttps://doi.org/10.1126/scitranslmed.abj5305

publisherhttps://www.science.org/doi/pdf/10.1126/scitranslmed.abj5305

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10176044

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34783582

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesInfluenza Virus Research Studies

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesmRNA VaccinesBNT162 VaccineAgedAluminum HydroxideAnimalsAntibodies, ViralHumansVaccines, SyntheticMiceAntibodies, NeutralizingPandemicsSpike Glycoprotein, Coronavirus

Keywords

AdjuvantCpG OligodeoxynucleotideSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorCpG siteVirologyVaccine adjuvantMedicineCoronavirus disease 2019 (COVID-19)HydroxideImmunologyBiologyChemistryInternal medicineGeneInfectious disease (medical specialty)DiseaseBiochemistry

Sustainable Development Goals

SDG 0: Good health and well-being